The 2017 Nobel Prize in Chemistry went to three scientists for their development of a new technology called cryo-electron microscopy (cryo-EM). This technique freezes proteins, and bombards them with electrons, allowing researchers to observe the building blocks of human cells. In a recent podcast by Proto, Luke Chao, PhD, a researcher in the department of molecularRead more
Blog
Massachusetts General Hospital recently established four endowed chairs. Meet the investigators whose work and contributions have been recognized through their appointment to these roles and please join us in congratulating them!
World AIDS Day takes place on the 1st of December each year. It’s an opportunity to highlight the success of worldwide efforts to combat HIV/AIDS, as well as the importance of continued support for these efforts.
Alzheimer's Disease, Anesthesia, Critical Care and Pain Medicine, Neurology | 0 comment | 27 November, 2017 | 0
How could the study of patients under anesthesia lead to a new way to diagnose Alzheimer’s disease? It could all come down to brainwaves.
Established in 2008, Harvard Catalyst | The Harvard Clinical and Translational Science Center is dedicated to improving human health by enabling collaboration and providing tools, training, and technologies to clinical and translational investigators.
Huntington’s disease (HD) is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain.
This September, actress and singer Selena Gomez announced on Instagram that she underwent a kidney transplant as part of her treatment for lupus, an autoimmune disease in which a body’s immune system begins to attack its own tissues and organs.
With the number of reported Lyme disease infections on the rise, Massachusetts General Hospital researchers are helping to meet the need for new diagnostic tools and treatments.
Diabetes impacts an estimated 425 million people around the world, and that number is projected to rise to 693 million by 2045, according to the annual diabetes atlas released today by the International Diabetes Federation (IDF).
Imagine enduring a painful, expensive and scar-inducing surgery—only to find out afterwards that it wasn’t necessary. This is the situation for many women with high-risk breast lesions.